4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-026200
Chief Operating Officer sold 3,586 shares at $42.34 ($151,831)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ADAMS R MARK Chief Operating Officer | 2021-04-07 | Sale | −3,586 | $42.34 | $151,831 | 67,018 | D: show line 1 in the form |
| Open-market sales · 3,586 sh · avg $42.34 · $151,831 | |||||||
Loading xslF345X03/doc4.xml…